|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q3 2021
Q3 2021
|
€836,739.00
|
|
August 19, 2026
|
Teagasc
|
Purchase Orders Over €20,000 Q2 2020
Q2 2020
|
€2,872,399.51
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q4 2021
Q4 2021
|
€856,998.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q1 2022
Q1 2022
|
€549,233.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q2 2022
Q2 2022
|
€622,012.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q3 2022
Q3 2022
|
€853,484.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q4 2022
Q4 2022
|
€1,030,813.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q1 2023
Q1 2023
|
€424,763.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q2 2023
Q2 2023
|
€747,102.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q3 2023
Q3 2023
|
€956,726.00
|
|
August 19, 2026
|
Teagasc
|
Purchase Orders Over €20,000 Q1 2020
Q1 2020
|
€5,824,536.40
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q4 2023
Q4 2023
|
€1,370,598.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q1 2024
Q1 2024
|
€779,701.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q2 2024
Q2 2024
|
€969,514.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q3 2024
Q3 2024
|
€750,903.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q4 2024
Q4 2024
|
€1,446,474.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q1 2025
Q1 2025
|
€624,423.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q2 2025
Q2 2025
|
€948,522.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q3 2025
Q3 2025
|
€874,872.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q4 2025
Q4 2025
|
€1,302,623.00
|
|
August 19, 2026
|
Teagasc
|
Purchase Orders Over €20,000 Q4 2019
Q4 2019
|
€3,527,174.27
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q1 2026
Q1 2026
|
€867,058.00
|
|
August 19, 2026
|
The Teaching Council
|
Purchase Orders over €20,000 Q2 2026
Q2 2026
|
€942,483.00
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q1 2021
Q1 2021
|
€466,711.62
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q2 2021
Q2 2021
|
€635,513.05
|
|
August 19, 2026
|
Teagasc
|
Purchase Orders Over €20,000 Q3 2019
Q3 2019
|
€1,865,566.95
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q3 2021
Q3 2021
|
€656,397.26
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q4 2021
Q4 2021
|
€555,434.00
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q1 2022
Q1 2022
|
€427,655.48
|
|
August 19, 2026
|
Teagasc
|
Purchase Orders Over €20,000 Q2 2019
Q2 2019
|
€4,404,997.08
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q2 2022
Q2 2022
|
€438,201.22
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q3 2022
Q3 2022
|
€453,126.90
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q4 2022
Q4 2022
|
€538,050.46
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q1 2023
Q1 2023
|
€572,455.56
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q2 2023
Q2 2023
|
€444,544.62
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q3 2023
Q3 2023
|
€474,653.75
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q4 2023
Q4 2023
|
€816,577.83
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q1 2024
Q1 2024
|
€391,519.48
|
|
August 19, 2026
|
Teagasc
|
Purchase Orders Over €20,000 Q1 2019
Q1 2019
|
€6,725,720.73
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q2 2024
Q2 2024
|
€539,344.68
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q3 2024
Q3 2024
|
€615,785.80
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q4 2024
Q4 2024
|
€795,209.13
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q1 2025
Q1 2025
|
€518,953.77
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q2 2025
Q2 2025
|
€777,212.86
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q3 2025
Q3 2025
|
€458,735.39
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q4 2025
Q4 2025
|
€580,742.98
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q1 2026
Q1 2026
|
€418,541.68
|
|
August 19, 2026
|
The Pharmacy Regulator
|
Payments or Invoices €20,000+ Q2 2026
Q2 2026
|
€399,331.96
|
|
August 19, 2026
|
Teagasc
|
Purchase Orders Over €20,000 Q4 2018
Q4 2018
|
€4,375,521.89
|
|
August 19, 2026
|
The Pensions Authority
|
Payments over €20,000 Q1 2020
Q1 2020
|
€472,089.83
|